Search

Search Results
Results 10161 - 10170 of 17271 for Active treatment
  • News - 29 May 2026
    Researchers mapped more than 11,000 transcriptomes across mice, rats, macaques, and humans, revealing conserved molecular signatures of aging and mortality across tissues, species, and cell types. The...
  • News - 27 May 2026
    The review highlights nanocarriers, microspheres, hydrogels, microneedles, long-acting formulations, and co-formulations as promising but mostly early-stage strategies that still require stronger...
  • Drug - 22 May 2026
    Consumer Medicine Information (CMI) about Qtern intended for persons living in Australia.
  • Drug - 20 May 2026
    Consumer Medicine Information (CMI) about Arava intended for persons living in Australia.
  • Drug - 18 May 2026
    Consumer Medicine Information (CMI) about Terimide intended for persons living in Australia.
  • Drug - 12 May 2026
    Consumer Medicine Information (CMI) about Sidapvia intended for persons living in Australia.
  • Drug - 12 May 2026
    Consumer Medicine Information (CMI) about Orlistat Viatris intended for persons living in Australia.
  • Drug - 12 May 2026
    Consumer Medicine Information (CMI) about Xigduo XR intended for persons living in Australia.
  • Drug - 11 May 2026
    Consumer Medicine Information (CMI) about Aldurazyme intended for persons living in Australia.
  • Drug - 8 May 2026
    Consumer Medicine Information (CMI) about Mersyndol Forte intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.